GCI Health surveyed almost 300 women in the PR and marketing industry to find out why self-care often falls to the bottom of their to-do list.
Experts predict the controversial tactic will be deployed far more widely this year, significantly impacting manufacturers — and, whether or not they realize it yet, patients.
We’ve got the usual predictions, plus backstories on a trio of pharma marketing practices.
Collaboration among payers and pharma companies is making a comeback, spurred by a renewed appetite for value-based contracting on medicines. And with a wave of extraordinarily high-priced, curative therapies right around the corner, the pace is about to pick way up.
Marketers answer the question: How can marketers take advantage of online health community forums to further drive patient engagement and trust?
From product design to social experiment to entertainment that turns into a product itself, these big tactical ideas are breaking new ground and challenging us to expand our thinking.
Cutting prescription drug prices has become one of the most popular campaign promises of our time.
Anders Dyhr Toft is a top innovation executive in Novo Nordisk’s Denmark headquarters.